Development of a lethal mast cell disease in mice reconstituted with bone marrow cells expressing the v-erbB oncogene.
An animal model for malignant mastocytosis is described in mice reconstituted with bone marrow cells expressing the v-erbB oncogene. The lethal mast cell disease is characterized by massive infiltration of bone marrow, spleen, and several other visceral organs by connective tissue mast cells, which normally reside in the skin and the peritoneal cavity. As is frequently found in malignant mastocytosis, the v-erbB-induced mast cell disease was accompanied in some primary recipients by an acute myelogenous leukemia (AML) that killed all secondary recipients regardless of whether the AML was already evident in the primary host. The infiltrating mast cells stained strongly positive with berberine sulfate, suggesting that they were terminally differentiated and in vitro they showed only a weak proliferative capacity. The leukemias were clonal but apparently of different origin than the malignant mast cells, implying the transformation of two independent cell populations. Leukemic cells expressed various myeloid-specific markers as well as the B220 antigen, normally associated with the B-cell lineage. However, the Ig heavy chain genes were still in germ line configuration. In culture, these cells proliferated in the absence of exogenous growth factors and had the capacity to differentiate into mature myeloid cells. Preliminary experiments suggest that v-erbB may use parts of a signal transduction pathway normally coupled to the c-kit receptor. The v-erbB-induced malignant mast cell disease should provide a useful animal model for elucidating the cause for malignant mastocytosis in humans and to explore possible therapeutic strategies.
Research Institute of Molecular Pathology (IMP), Vienna, Austria.
T
T
von Rüden
S
S
Kandels
T
T
Radaszkiewicz
A
A
Ullrich
E F
EF
Wagner
D001355:Alpharetrovirus / Q000235:genetics; D000818:Animals; D001853:Bone Marrow / Q000378:metabolism* / Q000473:pathology; D016026:Bone Marrow Transplantation; D002454:Cell Differentiation; D002455:Cell Division; D004195:Disease Models, Animal; D015870:Gene Expression; D005822:Genetic Vectors; D016130:Immunophenotyping; D015470:Leukemia, Myeloid, Acute / Q000209:etiology / Q000473:pathology; D008297:Male; D008407:Mast Cells / Q000473:pathology; D008415:Mastocytosis / Q000150:complications / Q000235:genetics* / Q000473:pathology; D051379:Mice; D008808:Mice, Inbred CBA; D018739:Oncogene Proteins v-erbB; D015682:Retroviridae Proteins, Oncogenic / Q000235:genetics*; D013154:Spleen / Q000473:pathology; D014162:Transfection
D018739:Oncogene Proteins v-erbB; D015682:Retroviridae Proteins, Oncogenic